We have presented evidence that DNA2 overexpression alleviates the impaired proliferation of U2OS and MCF10A cells after an activation of either H-Ras or cyclin E,33 suggesting that DNA2 could be an effective target in cancer therapy. This evidence concerns the gene CCNE1 and cancer.